Jake Nunn
Investing Profile
Sweet spot: $25M
Range: $50K–$50M
Sector and stage focus
- Seed: Pharmaceuticals, Social Networks, Health & Hospital Services
- Series B: Social Networks, Pharmaceuticals, Health & Hospital Services
- Series A: Pharmaceuticals, Health & Hospital Services, Social Networks
- general: San Francisco Bay Area
Recent investments by Jake Nunn
Jake Nunn has 5 named past investments in the public record. The most recent:
| Company | Stage | Date | Round size |
|---|---|---|---|
| TriVascular | Series E | Nov 2013 | $40M |
| Zenas BioPharma | Series C | May 2024 | $200M |
| Transcept Pharmaceuticals | Series D | Mar 2007 | $40M |
| Hyperion Therapeutics | Series C | Jun 2009 | $60M |
| Dermira | Series C | Aug 2014 | $51M |
Is Jake Nunn a fit for your round?
Upload your pitch deck and see whether Jake Nunn appears in your top 20 matches.
Find investors for your deck